USPTO serial 88382241
3D TUMORSPHERE MEDIUM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 1, 2020
- Examiner
- SHINN, LAUREN DONGMI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with 3D TUMORSPHERE MEDIUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
PromoCell bioscience alive GmbH Biomedizinische Produkte
Heidelberg, DE
Other trademarks owned by PromoCell bioscience alive GmbH Biomedizinische Produkte
PromoCell bioscience alive GmbH Biomedizinische Produkte
Heidelberg, DE
Other trademarks owned by PromoCell bioscience alive GmbH Biomedizinische Produkte
HEIDELBERG, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shoko Naruo
Shoko Naruo Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | bases, raw materials, auxiliaries and active ingredients, all being types of chemicals for use in industry and science for producing chemical, biochemical, biological and cell biological preparations; media for cell culture for use in the biotechnological industry and for non-medical research laboratories; biological preparation for use in cell cultures other than for medical or veterinary use; chemical products used in industry, namely, chemicals for use in in vitro research and development applications; biochemicals used in industry, namely, in in vitro research and development applications; biological preparations for use in industry; cytobiological preparations for use in industry; base materials, raw materials, auxiliary materials and active substances, all being types of chemicals for use in manufacturing biomedical and medical preparations | ACTIVE | — |
| 005 | medicines for regenerative purposes, cancer, cardio vascular diseases, respiratory diseases, dermatological diseases; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; sanitary preparations for medical use; [ dietetic foodstuffs adapted for medical use; foodstuff supplements adapted for medical use; plasters for medical use and bandages, wadding and gauze for dressings; ] chemical, biochemical, biological, cellular biological preparations for medical and biomedical science purposes, namely, cell and stem cell applications, regenerative solutions and for the treatment of cancer, dermatological diseases, respiratory diseases, cardio vascular diseases; cell cultures for cultivating human and animal cells, for medical purposes | ACTIVE | — |
| 010 | [ cell culture systems for medical use, namely, cell culture chambers used for human and animal cells ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PromoCell bioscience alive GmbH Biomedizinische Produkte
- Other trademarks owned by PromoCell bioscience alive GmbH Biomedizinische Produkte
- Other trademarks owned by PROMOCELL GMBH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named 3D TUMORSPHERE MEDIUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Sep 15, 2026 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Sep 7, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 8, 2026 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Sep 1, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 24, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 1, 2020 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Jul 28, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 22, 2020 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Jul 22, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 22, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 22, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 22, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 9, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 9, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 29, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 29, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 29, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 26, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 26, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 26, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 26, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 30, 2019 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| May 30, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 24, 2019 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 15, 2019 | NWAP | NEW APPLICATION ENTERED | — |